VCM
BHVN icon

Versant Capital Management’s Biohaven BHVN Stock Holding History

Versant Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96K Buy
468
+104
+29% +$1.12K ﹤0.01% 2352
2026
Q1 		$3.08K Buy
364
+202
+125% +$2.21K ﹤0.01% 2490
2025
Q4 		$1.83K Sell
162
-425
-72% -$5.26K ﹤0.01% 2458
2025
Q3 		$8.81K Buy
587
+576
+5,236% +$8.38K ﹤0.01% 1987
2025
Q2 		$155 Sell
11
-125
-92% -$2.23K ﹤0.01% 2608
2025
Q1 		$3.27K Sell
136
-92
-40% -$3.24K ﹤0.01% 2181
2024
Q4 		$8.52K Buy
+228
New +$10.6K ﹤0.01% 1496

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Versant Capital Management's BHVN Position: Q2 2026 in Review

Versant Capital Management increased its Biohaven (BHVN) stake by 29% in Q2 2026, buying an estimated $1.12K and bringing the position to 468 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

Versant Capital Management first reported a position in BHVN in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.81K in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Versant Capital Management held 468 shares of Biohaven worth $6.96K as of Q2 2026.
  • Versant Capital Management bought 104 Biohaven shares in Q2 2026, an estimated $1.12K.
  • Biohaven made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2352 holding.
  • Versant Capital Management first reported a position in Biohaven in Q4 2024 and has held it in 7 quarters since.
  • Versant Capital Management's Biohaven position peaked at $8.81K in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.